Image
Espansione My Mask

Espansione My-Mask - Treatment of MGD

Espansione My-Mask - Treatment of MGD. State of the art for MGD treatment

Pathology: MGD -> Medical Treatment: eye-light

  • Light modulation® / LLLT
  • Managed by physicians
  • Medical CE
  • Supportive treatment for serious levels
  • Complete treatment for less serious levels
  • New 2020 version

Also known as:

  • my-mask
  • my mask e
  • my-mask-e
  • my mask
  • my mask e

Call our expert team today on 01527 501077

Further Information

We developed my-mask® with convenience in mind.
Miniaturizing our Light Modulation® LLLT technology into such a portable, small package was a challenge we faced with the intention of providing operators and patients with a convenient yet powerful solution to benefit from light-based therapy wherever they feel like.

What are the benefits?
Built with the same, iconic industrial design of other Espansione solutions, my-mask® is powered by photobiomodulation technology enabling patients and operators to benefit from everything Red Light Modulation® Low Level Light Therapy (LM® LLLT) has to offer. The main difference with other solutions lies in my-mask®’s extremely lightweight, portable form factor. We developed this innovation to deliver the power of our Red Light Modulation® LLLT treatment to patients in the comfort of their home—or wherever they feel like.

  1. CONVENIENT
    my-mask® is an extremely lightweight, portable and convenient solution. Both the device’s body and the mask terminal have been designed to grant patients with the greatest comfort in administering (or self-administering) our light-based therapy (Light Modulation® LLLT).
  2. COMPLETE + DIRECT TREATMENT
    my-mask® enables a full therapy, covering both lower and upper eyelids, to grant maximum efficacy in treating Dry Eye Disease (DED) induced by Meibomian Glands Dysfunction (MGD) and other ocular surface conditions.
  3. TOTALLY PAINLESS
    my-mask® and LM® LLLT provide patients with an entirely painless therapy. Near-infrared light is emitted on the skin at a medically-certified wavelength, generating endogenous heating by stimulating cells’ ATP production.
  4. QUICK + EASY
    For patients, this means immediate relief just after the 15’ therapy—for operators, it means delivering greater value to patients, with much less effort.

About LM® LLLT
Our patented photobiomodulation technology (PBT) isn’t just like any other red light therapy. We patented and certified it for medical use, designing it to leverage near-infrared light beams that solicit cells’ mitochondria, triggering biochemical and biophysical reactions that stimulate them to a better protein synthesis. Thanks to this process of endogenous heating, the tear lipid layer is increased and stabilized.

Media Gallery
Image
Image
Available Downloads